Fidelity Investments’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Fidelity Investments’s Portfolio DSCI Stock Details DSCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-2,487,505	Closed	-$11.7M	–	2858
2015 Q3	$11.7M	Hold	2,487,505	–	–	﹤0.01%	1892
2015 Q2	$17.8M	Buy	2,487,505 +536,305	+27%	+$4.03M	﹤0.01%	1772
2015 Q1	$16.5M	Sell	1,951,200 -200	-0%	-$1.7K	﹤0.01%	1805
2014 Q4	$18.2M	Sell	1,951,400 -25,800	-1%	-$224K	﹤0.01%	1775
2014 Q3	$16.5M	Sell	1,977,200 -11,700	-0.6%	-$108K	﹤0.01%	1829
2014 Q2	$23M	Sell	1,988,900 -323,850	-14%	-$3.32M	﹤0.01%	1732
2014 Q1	$29.3M	Buy	2,312,750 +65,950	+3%	+$852K	﹤0.01%	1587
2013 Q4	$24.3M	Buy	2,246,800 +24,000	+1%	+$279K	﹤0.01%	1629
2013 Q3	$27.5M	Buy	2,222,800 +20,000	+0.9%	+$277K	﹤0.01%	1572
2013 Q2	$29.4M	Buy	+2,202,800	New	+$28.3M	﹤0.01%	1498

Other funds holding DSCI

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments's DSCI Position: Q4 2015 in Review

Fidelity Investments sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q4 2015, closing a stake of 2,487,505 shares — an estimated $11.7M sold.

Fidelity Investments first reported a position in DSCI in Q2 2013 and held it in 10 quarters. The position peaked at $29.4M in Q2 2013. 59 funds tracked by Wall St. Rank hold DSCI as of Q4 2015.

Fidelity Investments reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q4 2015 after selling out during the quarter.
Fidelity Investments sold 2,487,505 Derma Sciences, Inc. Common Stock (DE) shares in Q4 2015, an estimated $11.7M.
Fidelity Investments first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 10 quarters.
Fidelity Investments's Derma Sciences, Inc. Common Stock (DE) position peaked at $29.4M in Q2 2013.
59 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q4 2015.

Based on Fidelity Investments's 13F filing for Q4 2015, filed 12 Feb 2016.